Condition
Hematochezia
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05439772Phase 4Completed
Examining the Effect of Ondansetron on Bowel Prep Success
NCT03616041RecruitingPrimary
Capsule Endoscopy for Severe Hematochezia
NCT02536144Not ApplicableUnknown
The Clinical Application of MCCES in Examination of Human Colon
NCT00389935Phase 2Completed
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Showing all 4 trials